Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).
Click below to watch the entire symposium
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Eline Haijen, MSc
ADHD, Microdosing, Psychedelics
I am a PhD candidate in the Psychopharmacology in Maastricht research group at the Department of Neuropsychology and Psychopharmacology at Maastricht University. I am from a little village close to Maastricht.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Hongyu Zhao, MSc
My name is Hongyu, and I am a researcher from China. After completing my undergraduate degree in anesthesiology and obtaining a master's degree in psychiatry from a prestigious medical university in China.
Dr. Eef Theunissen
Cognition, Synthetic Cannabinoids, Drugs and Driving
I began my Ph.D. journey in 2001 at the Faculty of Psychology at the University of Maastricht. My research focused on investigating the sedating and stimulating effects of antihistamines, with a particular emphasis on their...
Dr. Rudy Schreiber
CNS Drug Discovery, Research Domain Criteria
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
Sarah Roche, MSc
Psilocybin, Sustainability, Environment
My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.
Henry Whitfeld, MSc
Psilocybin, Psychotherapy, Ideography
After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.
Prof. Jan Ramaekers
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance.
Dr. Conny Quaedflieg
Intentional Forgetting, EEG, Stress Resilience
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Psychedelic Research
Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study
→
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
→
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
creativity, divergent thinking, convergent thinking, Ayahuasca
→
Cannabis Research
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans
→
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.